JavaScript is disabled. Please enable to continue!
About Us >> Latest News >> CRO Leadership Award-seven consecutive years

CRO Leadership Award-seven consecutive years

Sidebar Image

Eurofins has proudly been a winner of the CRO Leadership Award for seven consecutive years. This year, Eurofins has been recognized for meeting or exceeding customer expectations in Capabilities, Compatibility, Quality and Reliability.

2018CROAwardLogos_Horizontal.jpg

Capabilities - We support all functional areas of bio/pharmaceutical manufacturing and have locations worldwide.

Compatibility - We are easy to work with and provide timely project communications.

Quality - We ensure our data meets customers' data quality expectations and global regulatory compliance requirements.

Reliability - We meet project timelines and milestones.

Martin_E_07_2x2.jpgDr. Gilles Martin
Founder & CEO

"It is an outstanding honor for Eurofins to receive the CRO Leadership award for Capabilities, Compatibility, Quality and Reliability. This achievement is aligned with our mission to provide our customers with innovative and high quality scientific services and we are delighted to know the bio/pharmaceutical industry continues to recognize Eurofins as a leader in these key areas."

 

For the 2018 CRO Leadership Awards, Life Science Leader magazine once again teamed up with Industry Standard Research (ISR) to determine the award recipients. More than 70 contract research organizations were assessed on 25+ performance metrics in ISR’s annual CRO Quality Benchmarkingsurvey.

For more information, please contact us

About Eurofins Pharma Bioanalytical Services

Eurofins Pharma Bioanalytical Services is a biologics- focused, global leader in bioanalytical solutions providing over 15 years of industry-leading scientific expertise. We specialize in comprehensive PK/TK, ADA, Nab, Biomarker assays and sample analysis for the world’s largest pharmaceutical and biopharmaceutical companies.

Our mission is to extend our clients capabilities of improving global health by combining scientific knowledge, capacity, regulatory expertise and flexibility to provide the trusted, relevant information required for the drug approval process.

At the forefront of employing novel approaches to overcome the most complex assay challenges and industry-leadership in developing and performing immunoassays on human and animal specimens, we offer trusted bioanalytical solutions to support studies ranging from a single plate to large, multi-national Phase III clinical trials, and we are equipped to handle variable sample numbers and large volumes to adapt to a client’s specific needs.